THE BOC GROUP, ITS SUBSIDIARIES BRING SUIT AGAINST FORMER EMPLOYEES, INHALON FOR CONSPIRACY, MISUSE OF TRADE SECRETS.LIBERTY CORNER, N.J.--(HealthWire)--March 29, 1995--The BOC (Bell Operating Company) One of 22 companies that was formerly part of AT&T and later organized into seven regional companies. See RBOC. Group, Inc., and its subsidiaries, Ohmeda Pharmaceutical Products Division Inc. (PPD (1) (Parallel Presence Detect) The method used by earlier SIMM memory modules to communicate their capacity to the computer. A binary number coming from a parallel set of pins was read by the system, with each pin representing one bit. Contrast with SPD. ) and Ohmeda Caribe Inc. (Caribe), have filed a lawsuit against Inhalon Pharmaceuticals, Inc., and four former company employees, who are now employees of Inhalon. Also named in the lawsuit is John P. Curran and Curran Capital Management. The lawsuit was filed in the Court of Common Pleas COURT OF COMMON PLEAS. The name of an English court which was established on the breaking up of the aula regis, for the determination of pleas merely civil. It was at first ambulatory, but was afterwards located. of Northampton County Northampton County is the name of several counties in the United States:
The lawsuit alleges that former company employees, Michael S. Fitiak, Douglas K. Kollmorgen, Ross C. Terrell and John M. Wynne breached contracts of employment with BOC and certain of its predecessors. The lawsuit further alleges that the four former employees and Inhalon conspired to, and did, misappropriate mis·ap·pro·pri·ate tr.v. mis·ap·pro·pri·at·ed, mis·ap·pro·pri·at·ing, mis·ap·pro·pri·ates 1. a. To appropriate wrongly: misappropriating the theories of social science. and misuse trade secrets of BOC in an attempt to manufacture and market versions of the anesthetic drugs isoflurane and enflurane to compete with those manufactured and marketed by PPD and Ohmeda Caribe. BOC also alleges that John P. Curran and Curran Capital Management joined in the conspiracy. Inhalon, based in Bethlehem, Pa., was established in 1991 and was recently acquired by Medeva, a major British pharmaceutical company, for $54 million. Inhalon plans to begin selling the drugs in April 1995, according to public statements issued by Medeva. The BOC Group is a $5.2 billion, U.K.-based company that has businesses in health care, industrial gases, vacuum technologies and distribution services. Ohmeda, the healthcare business of The BOC Group, is headquartered in Liberty Corner, N.J., employs approximately 5,300 people in 30 countries and had revenues of about $800 million in 1994. Ohmeda PPD develops and provides inhalation anesthetics and critical care pharmaceuticals. Contact: Judee Shuler (908) 771-4769 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion